|
CN104116866A
|
|
Traditional Chinese medicinal composition for treating cardia-cerebrovascular diseases
|
|
CN104095915A
|
|
Traditional Chinese medicine composition for treating diabetic foot
|
|
CN104096121A
|
|
Traditional Chinese medicine composition for treating sprain
|
|
CN104095940A
|
|
Traditional Chinese medicine composition for treating gout
|
|
CN104096187A
|
|
Traditional Chinese medicine composition for treating gout
|
|
CN103980288A
|
|
Production process of clopidogrel
|
|
CN103965058A
|
|
Process for producing memantine hydrochloride
|
|
CN103922925A
|
|
Production technology of Fenofibric acid
|
|
CN103860899A
|
|
Traditional Chinese medicine composition for treating diabetic foot
|
|
CN103860601A
|
|
Traditional Chinese medicine composition for treating benign prostatic hyperplasia
|
|
CN103860970A
|
|
Traditional Chinese medicine composition for treating dyspepsia
|
|
CN103833660A
|
|
Preparation method of lamotrigine and intermediate thereof
|
|
CN103694156A
|
|
Preparation method of psoriasis therapeutic medicine calcipotriol
|
|
CN103724162A
|
|
Preparation method of medicine calcipotriol solvate for treating psoriasis
|
|
CN103694307A
|
|
Preparation method of non-halogenated intermediate-acting cortical hormone desonide
|
|
CN103694306A
|
|
Method for preparing R-isomer by using S-isomer of budesonide
|
|
CN103664752A
|
|
Synthesis process for ibuprofen piconol
|
|
CN103772319A
|
|
Synthetic method of thiazepine compound
|
|
CN103664829A
|
|
Ranolazine synthesis technology
|
|
CN103664702A
|
|
Production process of rivastigmine
|
